Prevention of bone metastases in breast cancer
The paper deals with the prevention of bone metastases in patients with breast cancer (BC). The drugs from a group of bisphosphonates are ascertained to play an important role in combination therapy for bone metastases. Bonefos (clodronate) is one of these agents used in BC patients for prophylaxis.
Na minha lista:
Autor principal: | L. M. Kogonia (Autor) |
---|---|
Formato: | Livro |
Publicado em: |
ABV-press,
2014-08-01T00:00:00Z.
|
Assuntos: | |
Acesso em linha: | Connect to this object online. |
Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|
Registros relacionados
-
Pharmacoeconomic analysis of denosumab in patients with breast cancer and bone metastases
por: A. S. Kolbin, et al.
Publicado em: (2018) -
Current approaches to therapy for complications of bone metastases from breast cancer
por: L. G. Zhukova
Publicado em: (2014) -
Time course of changes in bone resorption markers during pamidronate therapy in breast cancer patients with bone metastases
por: A. D. Petrova, et al.
Publicado em: (2014) -
Machine learning predicts the prognosis of breast cancer patients with initial bone metastases
por: Chaofan Li, et al.
Publicado em: (2022) -
Scalp metastases in breast cancer
por: A. N. Mareeva, et al.
Publicado em: (2019)